GeneReach Biotechnology Corp. (TPEX:4171)

GeneReach Biotechnology Revenue

GeneReach Biotechnology had revenue of 60.03M TWD in the quarter ending June 30, 2026, with 10.14% growth. This brings the company's total for the last twelve months to 238.08M, up 6.10% year-over-year. In the year 2025, GeneReach Biotechnology had annual revenue of 232.74M with 12.71% growth. That makes GeneReach Biotechnology the 38,644th largest company in the world by revenue and 2,012th in Taiwan.

• Revenue (ttm): 238.08M
• Revenue Growth: +6.10%
• P/S Ratio: 3.94
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 938.16M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Other Countries 75.30M 32.4%
• Vietnam 32.67M 14.0%
• Taiwan 30.32M 13.0%
• India 23.37M 10.0%
• Indonesia 23.16M 9.9%
• The Philippines 22.18M 9.5%
• Saudi Arabia 13.58M 5.8%
• Panama 12.17M 5.2%

Fiscal year ended Dec 31, 2025 See the full GeneReach Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	232.74M	26.25M	12.71%
Dec 31, 2024	206.49M	-18.97M	-8.41%
Dec 31, 2023	225.46M	-524.56M	-69.94%
Dec 31, 2022	750.02M	-262.06M	-25.89%
Dec 31, 2021	1.01B	155.04M	18.09%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 26, 2026

Data Sources Report a data error